Search details
1.
Neoadjuvant Pertuzumab Plus Trastuzumab in Combination with Docetaxel and Carboplatin in Patients with HER2-Positive Breast Cancer: Real-World Data from the National Institute of Oncology in Poland.
Cancers (Basel)
; 14(5)2022 Feb 26.
Article
in English
| MEDLINE | ID: mdl-35267525
2.
Cytoplasmic HAX1 Is an Independent Risk Factor for Breast Cancer Metastasis.
J Oncol
; 2019: 6375025, 2019.
Article
in English
| MEDLINE | ID: mdl-31093284
Results
1 -
2
de 2
1
Next >
>>